Vera Therapeutics Inc (VERA)

Asset Type: Common Stock

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Description: Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.

Address: 170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, US

CIK: 1831828

Exchange: NASDAQ

Currency: USD

Country: USA

Fiscal Year End: December

Latest Quarter: June 30, 2024

Market Capitalization: 2,100,449,000

EBITDA: -90,727,000

PE Ratio: 0.00

PEG Ratio: 0.000

Book Value: 5.98

Dividend Per Share: 0.00

Dividend Yield: 0.0000

EPS: -2.15

Revenue Per Share (TTM): 0.00

Profit Margin: 0.000

Operating Margin (TTM): 0.000

Return on Assets (TTM): -0.247

Return on Equity (TTM): -0.461

Revenue (TTM): 0

Gross Profit (TTM): 0

Diluted EPS (TTM): -2.15

Quarterly Earnings Growth (YOY): 0.000

Quarterly Revenue Growth (YOY): 0.000

Analyst Target Price: 56.11

Analyst Ratings (Strong Buy): 3

Analyst Ratings (Buy): 6

Analyst Ratings (Hold): 1

Analyst Ratings (Sell): 0

Analyst Ratings (Strong Sell): 0

Trailing PE: 0.00

Forward PE: 0.00

Price to Sales Ratio (TTM): 0.000

Price to Book Ratio: 6.28

EV to Revenue: 0.000

EV to EBITDA: -3.60

Beta: 0.987

52 Week High: 50.78

52 Week Low: 9.24

50 Day Moving Average: 36.86

200 Day Moving Average: 34.46

Shares Outstanding: 54,828,000

Dividend Date: None

Ex-Dividend Date: None

Official Website: https://veratx.com